![]() |
Volumn 31, Issue 4, 2012, Pages 780-785
|
Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
ARTICLE;
CANCER PATIENT;
CANCER THERAPY;
DRUG COST;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HISTORY;
HUMAN;
INCOME;
MEDICAL FEE;
MEDICOLEGAL ASPECT;
OUTCOME ASSESSMENT;
PATIENT CARE;
REIMBURSEMENT;
SOCIETY;
DRUG COSTS;
HUMANS;
NEOPLASMS;
PHYSICIANS;
REIMBURSEMENT, INCENTIVE;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84862491905
PISSN: 02782715
EISSN: 15445208
Source Type: Journal
DOI: 10.1377/hlthaff.2012.0002 Document Type: Article |
Times cited : (48)
|
References (7)
|